VBI.H — Vivione Biosciences Balance Sheet
0.000.00%
FinancialsMicro Cap
Annual balance sheet for Vivione Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3.32 | 0.429 | 0.396 | 0.291 | 0.004 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.016 | 0.008 | 0 | — | 0.003 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.52 | 0.838 | 0.396 | 0.291 | 0.007 |
Net Property, Plant And Equipment | 0.124 | 0.234 | 0 | — | — |
Net Intangible Assets | |||||
Total Assets | 3.64 | 1.09 | 0.396 | 0.291 | 0.007 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.98 | 2.18 | 0.005 | 0.036 | 0.167 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.05 | 2.21 | 0.005 | 0.036 | 0.167 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.59 | -1.12 | 0.39 | 0.254 | -0.16 |
Total Liabilities & Shareholders' Equity | 3.64 | 1.09 | 0.396 | 0.291 | 0.007 |
Total Common Shares Outstanding |